Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Vertex claims JAK/CDK2 inhibitors for allergic and immune disorders

Jan. 20, 2004

Salix launches Azasan

Jan. 16, 2004

Significant improvements reported for tacrolimus ointment in cutaneous lupus erythematosus

Jan. 15, 2004

An anti-IL-5 antibody found safe and effective in patients with HES

Jan. 14, 2004

CYT-99-007 enters phase I

Jan. 14, 2004

Attenuated inflammatory response to sepsis found with N-acetylcysteine

Jan. 12, 2004

AMD-3100 induces the mobilization of hematopoietic progenitor cells in healthy volunteers

Jan. 8, 2004

JNJ-10329670 represents a new class of immunosuppressive compounds

Dec. 30, 2003

Menactra BLA submitted

Dec. 29, 2003

Inhibitors of IL-12 production prepared and tested at Taisho

Dec. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...